HCAT Stock Ownership Activity

HEALTH CATALYST INC 13F holders

1 value investing guru has made changes to the HEALTH CATALYST INC (HCAT) position according to the gurus' latest SEC quarterly report(s). The number of HCAT shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying HCAT now?

According to the latest SEC filing(s) HEALTH CATALYST INC (HCAT) has not been purchased by any super investor.

To see more about who is investing in HEALTH CATALYST INC (HCAT), please go to the HCAT ownership page.

2023 Q4 (1 result)
Brian Bares
-35.71%
-250,000
-0.09%
0.16%
Current price: $6.48 30.02% Reported price*: $9.26
2023 Q3 (1 result)
Brian Bares
-10.26%
-70,800
-0.03%
0.27%
Current price: $6.48 35.97% Reported price*: $10.12
2023 Q2 (1 result)
Brian Bares
+73.33%
+330,000
+0.14%
0.34%
Current price: $6.48 48.16% Reported price*: $12.50
2023 Q1 (1 result)
Brian Bares
-0.53%
-2,400
-0.00%
0.19%
Current price: $6.48 44.47% Reported price*: $11.67
2022 Q3 (1 result)
Brian Bares
+79.24%
+200,000
+0.08%
0.17%
Current price: $6.48 33.19% Reported price*: $9.70
2022 Q2 (1 result)
Brian Bares
+3.93%
+8,788
+0.01%
0.12%
Current price: $6.48 55.28% Reported price*: $14.49
2022 Q1 (2 results)
Brian Bares
+74.33%
+103,542
+0.06%
0.15%
Chase Coleman III
-100.00%
-50,000
-0.01%
0.00%
Current price: $6.48 75.20% AVG reported price*: $26.13
2021 Q3 (1 result)
Brian Bares
buy
+104,478
+0.12%
0.09%
Current price: $6.48 87.04% Reported price*: $50.01
2019 Q3 (1 result)
Chase Coleman III
buy
+50,000
+0.01%
0.01%
Current price: $6.48 79.52% Reported price*: $31.64
10 of 10

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.